drugset / Trial / NCT00519428

Does Dual Therapy Hasten Antidepressant Response?

NCT00519428

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will utilize a randomized double-blind design to evaluate whether initial treatment with two anti-depressant medications (escitalopram and bupropion) results in more rapid remission and greater over-all remission rates than either monotherapy in 240 depressed subjects.

Timeline

Start
2007-08
Primary completion
2011-07
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupropion Small molecule 450 mg
Comparator Escitalopram Small molecule 40 mg